Literature DB >> 9136067

Statistical comparison between dissolution profiles of drug products.

S C Chow1, F Y Ki.   

Abstract

The problem for assessment of similarity between dissolution profiles of two drug products is considered. The commonly used classical methods including model-dependent and model-independent approaches are reviewed. Most methods encountered the difficulties of no well-defined equivalence limits and the correlation between consecutive time points. Several methods have been proposed to account for these difficulties, e.g., the method of repeated measures (1) and the multivariate analysis approach (2). These methods, however, are sensitive to the selection of time points and complex covariance error structure. In this paper, we propose equivalence limits for similarity based on the amount of dissolved active ingredient as specified in the United States Pharmacopeia and National Formulary (USP/NF). Accordingly, we proposed a time series approach, which accounts for correlation between dissolution results at different time points. The proposed model is shown to be useful in assessment of similarity between dissolution profiles of two drug products. An example concerning dissolution testing of two lots of a drug product is used to illustrate the proposed equivalence limits and statistical methodology.

Mesh:

Year:  1997        PMID: 9136067     DOI: 10.1080/10543409708835184

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  5 in total

1.  DDSolver: an add-in program for modeling and comparison of drug dissolution profiles.

Authors:  Yong Zhang; Meirong Huo; Jianping Zhou; Aifeng Zou; Weize Li; Chengli Yao; Shaofei Xie
Journal:  AAPS J       Date:  2010-04-06       Impact factor: 4.009

2.  In vitro dissolution profile comparison--statistics and analysis of the similarity factor, f2.

Authors:  V P Shah; Y Tsong; P Sathe; J P Liu
Journal:  Pharm Res       Date:  1998-06       Impact factor: 4.200

3.  Assessment of dissolution profile of marketed aceclofenac formulations.

Authors:  T Soni; N Chotai
Journal:  J Young Pharm       Date:  2010-01

4.  Rehydrated sterically stabilized phospholipid nanomicelles of budesonide for nebulization: physicochemical characterization and in vitro, in vivo evaluations.

Authors:  Mohanad Naji Sahib; Yusrida Darwis; Kok Khiang Peh; Shaymaa Abdalwahed Abdulameer; Yvonne Tze Fung Tan
Journal:  Int J Nanomedicine       Date:  2011-10-14

5.  Nomogram for computing the value of similarity factor.

Authors:  M C Gohel; A Ramkishan; T M Patel; Radhika Pandya; Vrunda Suthar; Hiral Koradia; D V Madat; Shital Bariya; Tejal Mehta
Journal:  Indian J Pharm Sci       Date:  2014-05       Impact factor: 0.975

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.